E. Shalts et al., INHIBITORY EFFECT OF ARGININE-VASOPRESSIN ON LH-SECRETION IN THE OVARIECTOMIZED RHESUS-MONKEY, Neuroendocrinology, 59(4), 1994, pp. 336-342
Arginine-vasopressin (AVP) has been previously shown to act in synergi
sm with corticotropin-releasing hormone (CRH) in mediating stress-indu
ced changes in the hypothalamo-pituitary-adrenal (HPA) axis. We have p
reviously shown that both AVP and CRH play a role in mediating IL-1alp
ha-induced changes in gonadotropin secretion. In this study, we invest
igate the effects of exogenously administered AVP on luteinizing hormo
ne (LH) secretion in the ovariectomized (OVX) rhesus monkey. Adult OVX
rhesus monkeys were given an intracerebroventricular (ICV) infusion o
f AVP (I 5 mug/h, n = 8; 50 mug/h, n = 5). Control animals received an
ICV infusion of physiological saline at a rate 30 mul/h (n = 12). LH
concentrations were measured at 15-min intervals during a 3-hour prein
fusion morning baseline and 5-hour postinfusion period. Cortisol conce
ntrations were determined at 45-min intervals. Pulsatile LH release re
mained unchanged after a control saline infusion. After an AVP infusio
n, however, LH concentrations (ng/ml) significantly decreased (I 5 mug
: from 172.9 +/- 6.4 baseline to 129.4 +/- 5.3; 50 mug: from 142.8 +/-
8.3 to 106.7 +/- 6.0, mean +/- SE; p < 0.05). By the fifth hour of th
e AVP infusion, areas under the LH curve were 64.3 +/- 10.5 and 62.9 /- 11.0% of morning baseline for 15 and 50 gg hourly infusion rate, re
spectively. While cortisol concentrations decreased throughout the exp
erimental period in the animals receiving saline (a.m.: 35.4 +/- 2.4 m
ug/dl vs. p.m.: 27.7 +/- 1.9 mug/dl), they increased after AVP infusio
n (I 5 mug/h: 42.3 +/- 2.4 vs. 54.6 +/- 2.0 mug/dl; 50 mug/h: 41.9 +/-
6.6 vs. 50.8 +/- 8.5 mug/dl). These results provide compelling eviden
ce for a role of vasopressin not only in the regulation of the hypotha
lamo-pituitary-adrenal axis, but also of the hypothalamo-pituitary-gon
adal axis in the primate.